Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist

Carcinogenesis

Volumn 24, Issue 8, 2003, Pages 1317-1323

  Martin, Tracey A ^b   Parr, Christian ^b   Davies, Gaynor ^b   Watkins, Gareth ^b   Lane, Jane ^b   Matsumoto, Kunio ^a   Nakamura, T ^a   Mansel, Robert E ^b   Jiang, Wen G ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; CADHERIN; NK4; SCATTER FACTOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; REVIEW; TUMOR VOLUME;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL ADHESION; CELL DIVISION; CELL MOVEMENT; CYTOSKELETAL PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTE GROWTH FACTOR; HUMANS; MICE; MICE, NUDE; MITOGENS; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PAXILLIN; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-MET; SURVIVAL RATE; TUMOR CELLS, CULTURED; TYROSINE;

EID: 0041887145     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgg072     Document Type: Review

References (49)

1. Nakamura,T., Nishizawa,T., Hagiya, M., Seki,T., Shimonishi,M., Sugimura,A., Tashiro,K. and Shimizu,S. (1989) Molecular cloning and expression of human hepatocyte growth factor. Nature, 342, 440-443.
2. Nakamura,T. (1991) Structure and function of hepatocyte growth factor. Prog. Growth Factor Res., 3, 67-85.
3. Grant,D.S., Kleinman,H.K., Goldberg,I.D., Bhargava,M.M., Nickoloff,B.J., Kinsella,J.L., Polverini,P. and Rosen,E.M. (1993) Scatter factor induces blood vessel formation in vivo. Proc. Natl Acad. Sci. USA, 90, 1937-1941.
4. Corps,A., Sowter,H. and Smith,S. (1997) Hepatocyte growth factor stimulates motility, chemotaxis and mitogenesis in ovarian carcinoma cell expressing high levels of c-met. Int. J. Cancer, 73, 151-155.
5. Jiang,W.G. and Hiscox,S. (1997) Hepatocyte growth factor/scatter factor, a cytokine playing multiple and converse roles. Histol. Histopathol., 12, 537-555.
6. Rosen,E. (1993) Scatter factor induces blood-vessel formation in vivo. Proc. Natl Acad. Sci. USA, 9, 1937-1941.
7. Jiang,W.G., Hiscox,S., Matsumoto,K. and Nakamura,T. (1999) Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Crit. Rev. Oncol. Hematol., 29, 209-248.
8. Rosen,E., Meromsky,L., Setter,E., Vinter,D. and Goldberg,I. (1990) Purified scatter factor stimulates epithelial and vascular endothelial cell migration. Proc. Soc. Exp. Biol. Med., 195, 34-43.
9. Bussolina,B., DiRenzo,M. and Ziche,M. (1992) Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol., 119, 629-641.
10. Martin,T.A., Harding,K.G. and Jiang,W.G. (1999) Regulation of angiogenesis and endothelial cell motility by matrix-bound fibroblasts. Angiogenesis, 3, 69-76.
11. Dong,G., Chen,Z., Li,Z.Y., Yeh,N.T., Bancroft,C.C. and Van Waes,C. (2001) Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. Cancer Res., 61, 5911-5918.
12. Beviglia,L., Matsumoto,K., Lin,C.S., Ziober,B.L. and Kramer,R.H. (1997) Expression of the c-Met/HGF receptor in human breast carcinoma: correlation with tumor progression. Int. J. Cancer, 74, 301-309.
13. Yao,Y., Jin,L., Fuchs,A., Joseph,A., Hastings,H.M., Goldberg,I.D. and Rosen,E.M. (1996) Scatter factor protein levels in human breast cancers: clinicopathological and biological correlations. Am. J. Pathol., 149, 1707-1717.
14. Tuck,A.B., Park,M., Sterns,E.E., Boag,A. and Elliott,B.E. (1996) Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am. J. Pathol., 148, 225-232.
15. Edakuni,G., Sasatomi,E., Satoh,T., Tokunaga,O. and Miyazaki,K. (2001) Expression of the hepatocyte growth factor/c-Met pathway is increased at the cancer front in breast carcinoma. Pathol. Int., 51, 172-178.
16. Jin,L., Fuchs,A., Schnitt,S.J., Yao,Y., Joseph,A., Lamszus,K., Park,M., Goldberg,I.D. and Rosen,E.M. (1997) Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer, 79, 749-760.
17. Yamashita,J., Ogawa,M., Yamashita,S., Nomura,K., Kuramoto,M., Saishoji,T. and Shin,S. (1994) Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res., 54, 1630-1633.
18. Tsarfaty,I., Alvord,W.G., Resau,J.H. et al. (1999) Alteration of Met protooncogene product expression and prognosis in breast carcinomas. Anal. Quant. Cytol. Histol., 5, 397-408.
19. Taback,B., Chan,A.D., Kuo,C.T., Bostick,P.J., Wang,H.J., Giuliano,A.E. and Hoon,D.S. (2001) Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease. Cancer Res., 61, 8845-8850.
20. Camp,R.L., Rimm,E.B. and Rimm,D.L. (1999) Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma. Cancer, 86, 2259-2265.
21. Date,K., Matsumoto,K., Kuba,K., Shimura,H., Tanaka,M. and Nakamura,T. (1998) Inhibition of tumor growth and invasion by a four-kringle antagonist, (HGF/NK4) for hepatocyte growth factor. Oncogene, 17, 3045-3054.
22. Matsumoto,K., Kataoka,H., Date,K. and Nakamura,T. (1998) Cooperative interaction between alpha- and beta-chains of hepatocyte growth factor on c-Met receptor confers ligand-induced receptor tyrosine phosphorylation and multiple biological responses. J. Biol. Chem., 273, 22913-22920.
23. Date,K., Matsumoto,K., Shimura,H., Tanaka,M. and Nakamura,T. (1997) HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor. FEBS Lett., 420, 1-6.
24. Kuba,K., Matsumoto,K., Ohnishi,K., Shiratsuchi,T., Tanaka,M. and Nakamura,T. (2000) Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells. Biochem. Biophys. Res. Commun., 279, 846-852.
25. Parr,C., Davies,G., Nakamura,T., Matsumoto,K., Mason,M.D. and Jiang,W.G. (2001) The HGF/SF-induced phosphorylation of paxillin, matrix adhesion and invasion of prostate cancer cells were suppressed by NK4, an HGF/SF variant. Biochem. Biophys. Res. Commun., 285, 1330-1337.
26. Saga,Y., Mizukami,H., Suzuki,M., Urabe,M., Kume,A., Nakamura,T., Sato,I. and Ozawa,K. (2001) Expression of HGF/NK4 in ovarian cancer cells suppresses intraperitoneal dissemination and extends host survival. Gene Ther., 8, 1450-1455.
27. Seki,I., Ihara,I. and Sugimura,S. (1990) Isolation and expression of cDNA for different forms of hepatocyte growth factor from human leukocytes. Biochem. Biophys. Res. Commum., 172, 321-327.
28. Jiang,W.G., Hiscox,S., Nakamura,T., Hallett,M.B., Puntis,M.C.A. and Mansel,R.E. (1996) Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (FAK) and paxillin and enhances cell-matrix interactions. Oncol. Rep., 3, 819-823.
29. Liu,Z.X., Yu,C.F., Nickel,C., Thomas,S. and Cantley,L.G. (2002) Hepatocyte growth factor induces ERK-dependent paxillin phosphorylation and regulates paxillin-focal adhesion kinase association. J. Biol. Chem., 277, 10452-10458.
30. Huber,P., Dalma,J., Engiles,J., Brevario,F., Gory,S., Siracusa,L.D., Buchberg,A.M. and Dejana,E. (1996) Genomic structure and chromosomal mapping of the mouse. Genome, 32, 21-28.
31. Liu,Y., Michalopoulos,G.K. and Zarnegar,R. (1999) Molecular cloning and characterisation of cDNA encoding mouse hepatocyte growth factor. Biochim. Biophys. Acta, 1216, 299-303.
32. Ono,M., Torisu,H., Fukushi,J., Nishie,A. and Kuwano,M. (1993) Biological implications of macrophage infiltration in human tumour angiogenesis. Cancer Chemother. Pharmacol., 43, S69-S71.
33. Jiang,W.G., Hiscox,S.E., Parr,C., Martin,T.A., Matsumoto,K., Nakamura,T. and Mansel,R.E. (1999) Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells. Clin. Cancer Res., 5, 3695-3703.
34. Jin,L., Fuchs,A., Schnitt,S.J., Yao,Y., Joseph,A., Lamszus,K., Park,M., Goldberg,I.D. and Rosen,E.M. (1997) Expression of scatter factor and c-met receptor in benign and malignant breast tissue. Cancer, 79, 749-760.
35. Yamashita,J., Ogawa,M. and Beppu,T. (1993) Immunoreactive hepatocyte growth factor is present in tissue extracts from human breast cancer but not in conditioned medium of human breast cancer cell lines. Res. Commun. Chem. Pathol. Pharmacol., 82, 249-252.
36. Brooks,P.C. (1996) Cell adhesion molecules in angiogenesis. Cancer Metastasis Rev., 15, 187-194.
37. Folkman,J. (1996) New perspectives in clinical oncology from angiogenesis research. Eur. J. Cancer, 32A, 2534-2539.
38. Folkman,J. and Shing,Y. (1992) Angiogenesis. J. Biol. Chem., 267, 10931-10934.
39. Martin,T.A., Harding,K. and Jiang,W.G. (2001) Matrix-bound fibroblasts regulate angiogenesis by modulation of VE-cadherin. Eur. J. Clin. Invest., 31, 931-938.
40. Martin,T.A., Mansel,R. and Jiang,W.G. (2001) Hepatocyte growth factor modulates vascular endothelial-cadherin expression in human endothelial cells. Clin. Cancer Res., 7, 734-737.
41. Tomioka,D., Maehara,N., Kuba,K., Mizumoto,K., Tanaka,M., Matsumoto,K. and Nakamura,T. (2001) Inhibition of growth, invasion and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model. Cancer Res., 61, 7518-7524.
42. Maehara,N., Matsumoto,K., Kuba,K., Mizumoto,K., Tanaka,M. and Nakamura,T. (2001) NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells. Br. J. Cancer, 84, 864-873.
43. Hiscox,S., Parr,C., Nakamura,T., Matsumoto,K., Mansel,R.E. and Jiang,W.G. (2000) Inhibition of HGF/SF-induced breast cancer cell motility and invasion by the HGF/SF variant, NK4. Breast Cancer Res. Treat., 59, 245-254.
44. Parr,C., Hiscox,S., Nakamura,T., Matsumoto,K. and Jiang,W.G. (2000) NK4, a new HGF/SF variant, is an antagonist to the influence of HGF/SF on the motility and invasion of colon cancer cells. Int. J. Cancer, 85, 563-570.
45. Lohr,J.W., Lee,T.P., Farooqui,M. and Mookerjee,B.J. (2000) Increased levels of serum hepatocyte growth factor in patients with end-stage renal disease. J. Med., 31, 131-141.
46. Han,S.U., Lee,J.H., Kim,W.H., Cho,Y.K. and Kin,M.W. (1999) Significant correlation between serum level of hepatocyte growth factor and progression of gastric carcinoma. World J. Surg., 23, 1176-1180.
47. Robak,E., Wozniacka,A., Sysa-Jedrzejowska,A., Stepien,H. and Robak,T. (2001) Serum levels of angiogenesis cytokines in systemic lupus erythematosus and their correlation with disease activity. Eur. Cytokine Netw., 12, 445-452.
48. Day,R.M., Cioce,V., Breckenridge,D., Castagnino,P. and Bottaro,D.P. (1999) Differential signaling by alternative HGF isoforms through c-Met: activation of both MAP kinase and PI 3-kinase pathways is insufficient for mitogenesis. Oncogene, 18, 3399-3406.
49. Skobe,M., Rockwell,P., Goldstein,N., Vosseler,S. and Fusenig,N.E. (1997) Halting angiogenesis suppresses carcinoma cell invasion. Nature Med., 3, 1222-1227.